Step Therapy

What this guide covers

Step Therapy (also called fail first) is when a plan requires the patient to try one or more lower-cost or preferred drugs before it will pay for the medication the prescriber ordered.

Beginner advocates hear: "Your insurance wants you to try something else first." This guide explains what that means, how to document prior trials, and how to request an override when the required steps are unsafe or already done.

Pair with Formularies & Drug Tiers (ST on the drug list) and Rx Prior Authorization (often required after steps are documented).

This is educational information, not medical advice. Only the prescriber decides which drug is appropriate.

What step therapy is

The plan publishes a sequence—for example, try generic Drug A for eight weeks, then Drug B, before covering Drug C. Until the sequence is satisfied or waived, the pharmacy claim for Drug C rejects.

Step therapy is not the same as prior authorization, which is clinical review of one drug and may still apply after steps are met. It is not a formulary exception, which covers a drug not on the list at all. It is not a quantity limit, which caps how much can be filled per month. A single drug can show ST + PA + QL on the formulary—all must be cleared before a smooth fill.

Why plans require it

Plans use step therapy to steer prescribing toward drugs with lower net cost or established first-line evidence. For advocates, the policy debate matters less than the documentation task: prove the required steps happened—or why they should be skipped for this patient.

How you know ST applies

The formulary search may show STon the prescribed drug. The pharmacy reject may reference step therapy, a prerequisite drug, or "not on step protocol." A plan letter may list required trial medications and minimum duration.

Ask the plan or PBM for the step therapy criteria document for that drug—often on the provider portal. Criteria spell out exact drugs, doses, and weeks of therapy required.

Meeting the step requirements

What counts as a trial

Plans typically want the drug name and strength to match the step list—not a close cousin unless the criteria allow it. They want a minimum duration (often four to twelve weeks at a therapeutic dose), the reason the trial ended (ineffective, side effects, contraindication, allergy), and dates of use plus which prescriber managed the trial.

A few days on a sample pack or a sub-therapeutic dose may notcount. Read the plan's criteria literally.

Document prior trials

Ask the prescriber to attach a short table: medication tried, dates, dose, outcome (failed, intolerant, contraindicated). Add pharmacy fill history from one chain or chart notes. Include hospital records if the trial happened during an admission.

Patients often remember trials the plan does not see on claims—still worth documenting, but chart notes or pharmacy records strengthen the packet. Use habits from Building a strong appeal packet.

Step therapy override

When required steps are inappropriate, the prescriber requests a step therapy override—wording varies: step edit exception, ST waiver. Plans often accept contraindication or allergy to the step drug, a serious adverse event, a step drug likely ineffective for this diagnosis (with clinical rationale), proof the patient already completed required trials, or urgent need when delay would harm the patient (request expedited review).

Some states require plans to grant overrides when criteria are met—check Insurance topic state PA guides for step therapy language if the patient has regulated commercial coverage.

Step therapy vs prior auth

Step therapy answers: Did the patient try the required drugs first? Prior authorization answers: Is this specific prescription medically appropriate and covered under plan rules?

Workflow is often: document or override steps, then submit PA if the formulary still shows PA, then fill at the pharmacy. Skipping step one when ST is on the formulary causes repeated rejects even with a strong PA letter.

Medicare, Medicaid & commercial

Medicare Part D uses step therapy as a utilization management tool; overrides are part of coverage determinations and exceptions. Appeals follow Part D timelines—see Medicare Part D Drug Appeals. Medicaid managed care formularies and state preferred drug lists may require steps; fair hearing rights may apply after plan denials. Commercial and marketplace plans use PBM criteria; some states limit step therapy with required override grounds or appeal rights—use state Insurance guides when the plan is fully insured in that state.

If the requested drug is not on formulary, you may need a formulary exception in addition to—or instead of—a step override. See Formulary & Tiering Exceptions.

What advocates should do

Before the prescriber visit

Look up the drug on the plan formulary and note ST, PA, and QL. Download or print step criteria for the requested drug. List every related medication the patient has tried, with dates from pharmacy records or charts. Bring the list to the appointment so the prescriber can order the right sequence or request an override upfront.

After a step denial

Get the written denial reason and reference number. Compare the denial to the criteria—which step does the plan say was missing? Ask the prescriber to submit an override with targeted documentation, not a generic letter. Calendar the appeal deadline—see Denied Prescriptions. Arrange a bridge supply with the prescriber if stopping the drug is unsafe.

Scenarios beginners run into

Tried required drug years ago

Plans may not see old fills if the patient changed pharmacies or plans. The prescriber documents the prior trial with dates and outcome; attach a pharmacy printout or chart notes. Request an override if fills are unavailable but the history is clear.

Could not tolerate step drug

Document adverse effects in the chart and letter—"intolerance" without detail may lose. Include an ER visit, labs, or stopped due to rash with dates.

Plan lists wrong step drug

Criteria may name a drug not used for this condition. The prescriber explains in peer-to-peer or a letter why the listed step is clinically inappropriate—cite guidelines if the office uses them.

New start on expensive biologic

Common in rheumatology, dermatology, and GI. Expect ST plus PA. Start step documentation early. Biologics should not wait weeks without a plan if the condition is active—press for an expedited override when appropriate.

Step therapy and PA both required

Complete the override or step documentation first. After the plan confirms steps are satisfied, submit PA if still required. Verify both flags are cleared before the patient travels to the pharmacy.

Switching plans mid-treatment

A new plan may not honor the old plan's step completion. Gather proof of prior fills immediately after enrollment and submit an override with the first fill attempt on the new plan.

Related guides

Formularies & Drug Tiers, Rx Prior Authorization, Formulary & Tiering Exceptions, Quantity Limits, Denied Prescriptions, and Prescription Coverage Basics.

Official resources

Medicare.gov — Part D drug coverage & rights. CMS — Part D benefits (utilization management). NCSL — State policy on prescription drug affordability (includes step therapy reforms).